Brief: Interpace Biosciences Q3 Revenue USD 12.295 Million

Interpace Biosciences

04/11/2024 21:30

Nov 04 (Reuters) - Interpace Biosciences Q3 net income USD 1.28 million.
* Q3 operating income USD 1.905 million
* Q3 gross profit USD 7.506 million
* Q3 net income continuing operations USD 1.362 million
* Q3 operating expenses USD 5.601 million